Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Tax Provisions (2023 - 2025)

Axsome Therapeutics' Tax Provisions history spans 3 years, with the latest figure at $500000.0 for Q4 2025.

  • For Q4 2025, Tax Provisions rose 488.24% year-over-year to $500000.0; the TTM value through Dec 2025 reached -$500000.0, down 688.24%, while the annual FY2025 figure was -$500000.0, 688.24% down from the prior year.
  • Tax Provisions for Q4 2025 was $500000.0 at Axsome Therapeutics, up from -$40000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.6 million in Q1 2023 and bottomed at -$960000.0 in Q2 2025.
  • The 3-year median for Tax Provisions is -$171500.0 (2023), against an average of $68125.0.
  • The largest annual shift saw Tax Provisions surged 128.05% in 2024 before it skyrocketed 488.24% in 2025.
  • A 3-year view of Tax Provisions shows it stood at -$303000.0 in 2023, then soared by 128.05% to $85000.0 in 2024, then surged by 488.24% to $500000.0 in 2025.
  • Per Business Quant, the three most recent readings for AXSM's Tax Provisions are $500000.0 (Q4 2025), -$40000.0 (Q3 2025), and -$960000.0 (Q2 2025).